These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35067473)

  • 21. Corrigendum to "Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway" [Int. Immunopharmacol. 36 (2016) 132-141].
    Yao H; Hu C; Yin L; Tao X; Xu L; Qi Y; Han X; Xu Y; Zhao Y; Wang C; Peng J
    Int Immunopharmacol; 2019 Sep; 74():105786. PubMed ID: 31402320
    [No Abstract]   [Full Text] [Related]  

  • 22. Corrigendum to "Hydrogen gas inhalation enhances alveolar macrophage phagocytosis in an ovalbumin-induced asthma model" [Int. Immunopharmacol. 74 (2019) 105646].
    Huang P; Wei S; Huang W; Wu P; Chen S; Tao A; Wang H; Liang Z; Chen R; Yan J; Zhang Q
    Int Immunopharmacol; 2022 Nov; 112():109124. PubMed ID: 36070977
    [No Abstract]   [Full Text] [Related]  

  • 23. Corrigendum to "Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppressing TGF-β1 production and TGF-β1-induced fibroblasts differentiation" [Int Immunopharmacol. 74 (2019) 105696].
    Nie Y; Zhang D; Qian F; Wu Y
    Int Immunopharmacol; 2022 Mar; 104():108496. PubMed ID: 35016851
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to "Oleamide suppresses inflammatory responses in LPS-induced RAW264.7 murine macrophages and alleviates paw edema in a carrageenan-induced inflammatory rat model" [Int. Immunopharmacol. 56 (2018) 179-185].
    Moon SM; Lee SA; Hong JH; Kim JS; Kim DK; Kim CS
    Int Immunopharmacol; 2018 Jul; 60():246. PubMed ID: 29789261
    [No Abstract]   [Full Text] [Related]  

  • 25. Corrigendum to "(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol alleviates inflammatory responses in LPS-induced mice liver sepsis through inhibition of STAT3 phosphorylation" [Int. Immunopharmacol. 125(Part B) (2023) 111124].
    Kim B; Yu JE; Yeo IJ; Son DJ; Lee HP; Roh YS; Lim KH; Yun J; Park H; Han SB; Hong JT
    Int Immunopharmacol; 2024 Aug; 137():112543. PubMed ID: 38926074
    [No Abstract]   [Full Text] [Related]  

  • 26. Corrigendum to "Pseudomonas aeruginosa-mannose sensitive hemagglutinin injection treated cytokine-induced killer cells combined with chemotherapy in the treatment of malignancies" [Int. Immunopharmacol. 51 (2017) 57-65].
    Zhang C; Zhang Z; Wang L; Han J; Li F; Shen C; Li H; Huang L; Zhao X; Yue D; Huang J; Yan Y; Zhang Y
    Int Immunopharmacol; 2022 Jan; 102():108356. PubMed ID: 34794888
    [No Abstract]   [Full Text] [Related]  

  • 27. Corrigendum to "Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway" [Int. Immunopharmacol. 75 (2019) 105759].
    Wen S; Wei Y; Zhang X; Bai F; Tan S; Nie J; Wei J; Lin X
    Int Immunopharmacol; 2021 Mar; 92():107344. PubMed ID: 33418247
    [No Abstract]   [Full Text] [Related]  

  • 28. Corrigendum to "Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats" [Int. Immunopharmacol. 72 (2019) 211-217].
    Xia W; Zhang H; Pan Z; Li G; Zhou Q; Hu D; Liu Y
    Int Immunopharmacol; 2023 Sep; 122():110699. PubMed ID: 37500384
    [No Abstract]   [Full Text] [Related]  

  • 29. Corrigendum to "Maclurin inhibits caspase-11 non-canonical inflammasome in macrophages and ameliorates acute lethal sepsis in mice" [Int. Immunopharmacol. 129 (2024) 111615].
    Lee DJ; Lee SY; Yi YS
    Int Immunopharmacol; 2024 May; 132():111969. PubMed ID: 38575463
    [No Abstract]   [Full Text] [Related]  

  • 30. Corrigendum to "Inhibitory effect of valproate sodium on pain behavior in diabetic mice involves suppression of spinal histone deacetylase 1 and inflammatory mediators" [Int. Immunopharmacol. 70 (2019) 16-27].
    Elsherbiny NM; Ahmed E; Abdel Kader G; Abdel-Mottaleb Y; ElSayed MH; Youssef AM; Zaitone SA
    Int Immunopharmacol; 2023 Apr; 117():109807. PubMed ID: 36890025
    [No Abstract]   [Full Text] [Related]  

  • 31. Corrigendum to "Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis" [Int. Immunopharmacol. 77 (2019) 105968].
    Jiang Y; Hu F; Li Q; Shen C; Yang J; Li M
    Int Immunopharmacol; 2020 Jul; 84():106318. PubMed ID: 32115350
    [No Abstract]   [Full Text] [Related]  

  • 32. Corrigendum to "IDO1: An important immunotherapy target in cancer treatment" [Int. Immunopharmacol. 47 (2017) 70-77].
    Li F; Zhang R; Li S; Liu J
    Int Immunopharmacol; 2017 Aug; 49():231. PubMed ID: 28457914
    [No Abstract]   [Full Text] [Related]  

  • 33. Corrigendum to "Chrysophanol facilitates long-term neurological recovery through limiting microglia-mediated neuroinflammation after ischemic stroke in mice" [Int. Immunopharmacol. 112 (2022) 109220].
    Liu X; Zhang X; Chen J; Song D; Zhang C; Chen R; Xu R; Jiang W; Li L
    Int Immunopharmacol; 2024 Jul; ():112620. PubMed ID: 38969587
    [No Abstract]   [Full Text] [Related]  

  • 34. Corrigendum to "Immune response of C57BL/6J mice to herpes zoster subunit vaccines formulated with nanoemulsion-based and liposome-based adjuvants" [Int. Immunopharmacol. 101(Part B) (2021) 108216].
    He L; Sun B; Guo Y; Yan K; Liu D; Zang Y; Jiang C; Zhang Y; Kong W
    Int Immunopharmacol; 2023 Jun; 119():110260. PubMed ID: 37150708
    [No Abstract]   [Full Text] [Related]  

  • 35. Corrigendum to "Icariin targets Nrf2 signaling to inhibit microglia-mediated neuroinflammation" [Int. Immunopharmacol. 73 (2019) 304-311].
    Zheng Y; Zhu G; He J; Wang G; Li D; Zhang F
    Int Immunopharmacol; 2020 Nov; 88():107004. PubMed ID: 32950402
    [No Abstract]   [Full Text] [Related]  

  • 36. Corrigendum to "Effect of chlorogenic acid on mast cell-dependent anaphylactic reaction" [Int. Immunopharmacol. 10 (2010) 1135-1141].
    Qin HD; Shi YQ; Liu ZH; Li ZG; Wang HS; Wang H; Liu ZP
    Int Immunopharmacol; 2019 Nov; 76():105863. PubMed ID: 31473097
    [No Abstract]   [Full Text] [Related]  

  • 37. Corrigendum to "Immune-enhancing effects of polysaccharides extracted from Lilium lancifolium Thunb" [Int. Immunopharmacol. 52 (2017) 119-126].
    Pan G; Xie Z; Huang S; Tai Y; Cai Q; Jiang W; Sun J; Yuan Y
    Int Immunopharmacol; 2018 May; 58():186. PubMed ID: 29599101
    [No Abstract]   [Full Text] [Related]  

  • 38. Corrigendum to "Circulating midkine in children with Henoch-Schönlein purpura: Clinical implications" [Int. Immunopharmacol. (2016) 246-250].
    Su Z; Lv X; Liu Y; Zhang J; Guan J; Gai Z
    Int Immunopharmacol; 2016 Dec; 41():145. PubMed ID: 27612398
    [No Abstract]   [Full Text] [Related]  

  • 39. Corrigendum to "Isosteroid alkaloids with different chemical structures from Fritillariae cirrhosae bulbus alleviate LPS-induced inflammatory response in RAW 264.7 cells by MAPK signaling pathway" [Int. Immunopharmacol. 78 (2020) 106047].
    Liu S; Yang T; Ming TW; Gaun TKW; Zhou T; Wang S; Ye B
    Int Immunopharmacol; 2020 Jul; 84():106482. PubMed ID: 32278661
    [No Abstract]   [Full Text] [Related]  

  • 40. Corrigendum to "Tryptase inhibitor APC 366 prevents hepatic fibrosis by inhibiting collagen synthesis induced by tryptase/protease-activated receptor 2 interactions in hepatic stellate cells" [Int. Immunopharmacol. 20 (2014) 352-357].
    Lu J; Chen B; Li S; Sun Q
    Int Immunopharmacol; 2019 Apr; 69():408. PubMed ID: 30755386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.